Literature DB >> 241383

Nonequivalence of the metal binding sites in vanadyl-labeled human serum transferrin.

J C Cannon, N D Chasteen.   

Abstract

Vanadyl ion, VO(IV), has been used as an electron paramagnetic resonance (EPR) spin label to study the metal-binding properties of human serum transferrin in the presence of bicarbonate. Iron-saturated transferrin does not bind the vanadyl ion. Room temperature titrations of apotransferrin with VO(IV) as monitored by EPR indicate the extent of binding to be pH dependent, with a full 0.2 VO(IV) ions per transferrin molecule bound at pH 7.5 and 9, but only about 1.2 VO(IV) ions bound at pH 6. The EPR spectra of frozen solutions with or without 0.1 M NaCUO4 at 77 K show that there are two spectroscopically nonequivalent binding sites (A and B) with a slight difference in binding constants. One site (A site) exhibits essentially constant binding capacity in the pH range 6-9, but the other (B site) becomes less avialable as the pH is reduced below 7. Results with mixed Fe(III)-VO(IV) transferrin complexes suggest that iron shows a slight tendency to bind at the B site over the A site pH 7.5 and 9.0. Only the B site in both vanadyl and iron transferrins is perturbed by the presence of perchlorate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241383     DOI: 10.1021/bi00692a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  An extended-X-ray-absorption-fine-structure study of freeze-dried and solution ovotransferrin. Evidence for water co-ordination at the metal-binding sites.

Authors:  S S Hasnain; R W Evans; R C Garratt; P F Lindley
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

2.  A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds.

Authors:  Daniele Sanna; Péter Buglyó; Giovanni Micera; Eugenio Garribba
Journal:  J Biol Inorg Chem       Date:  2010-03-26       Impact factor: 3.358

3.  Exploring the Fe(III) binding sites of human serum transferrin with EPR at 275 GHz.

Authors:  Guinevere Mathies; Peter Gast; N Dennis Chasteen; Ashley N Luck; Anne B Mason; Edgar J J Groenen
Journal:  J Biol Inorg Chem       Date:  2014-12-24       Impact factor: 3.358

Review 4.  Transferrin-mediated cellular iron delivery.

Authors:  Ashley N Luck; Anne B Mason
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

5.  Antibacterial effect of scandium and indium complexes of enterochelin on Klebsiella pneumoniae.

Authors:  H J Rogers; C Synge; V E Woods
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

6.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

7.  Mössbauer studies of electrophoretically purified monoferric and diferric human transferrin.

Authors:  S A Kretchmar; M Teixeira; B H Huynh; K N Raymond
Journal:  Biol Met       Date:  1988

8.  Iron uptake from rat plasma transferrin by rat reticulocytes.

Authors:  H Huebers; E Huebers; E Csiba; C A Finch
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

9.  Pharmacokinetics of vanadium in humans after intravenous administration of a vanadium containing albumin solution.

Authors:  Günter Heinemann; Burckhard Fichtl; Wolfgang Vogt
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

10.  Ferric pyrophosphate citrate: interactions with transferrin.

Authors:  Raymond Pratt; Garry J Handelman; Thomas E Edwards; Ajay Gupta
Journal:  Biometals       Date:  2018-10-11       Impact factor: 2.949

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.